NOTE 1  ORGANIZATION AND DESCRIPTION OF BUSINESS Organicell Regenerative Medicine, Inc. (formerly Biotech Products Services and Research, Inc.) (Organicell or the Company) was incorporated on August 9, 2011 in the State of Nevada. On May 29, 2015, Albert Mitrani acquired controlling interest of Organicell through the purchase of 135,000,000 shares of common stock from John Goodhew and subsequently became a director and the sole officer of Organicell. Until October 30, 2015, the Companys business included the designing, manufacturing, and selling vending tricycles for commercial customers. On October 30, 2015, the Company entered into a stock purchase agreement (the Purchase Agreement) with John Goodhew, the Company's director, pursuant to which all of the shares of Bespoke Tricycles, Ltd. (Bespoke), a corporation organized under the Laws of England and Wales, were transferred to Mr. Goodhew. As a result of such sale, the Company was no longer in the business of designing, manufacturing, and selling vending tricycles. The purchase price for the shares sold to Mr. Goodhew was $10. On April 23, 2018, the Company and Management and Business Associates, LLC, a Florida limited liability company (MBA), executed a Plan and Agreement of Reorganization (Reorganization), whereby the Company issued to MBA an aggregate of 222,425,073 shares of its common stock of the Company, representing at the time 51% of the outstanding shares of common stock of the Company on fully-diluted basis, for $0.001 per share (or an aggregate of $222,425), in consideration for MBAs founder and Chief Executive Officer, Mr. Manuel Iglesias agreement to serve as the Companys Chief Executive Officer (CEO) and a member of the Board of the Company. The Reorganization was effective as of April 13, 2018 (Effective Date). The Reorganization also provided for the cancelation and termination of the Companys previously issued and outstanding Series A Preferred Stock and Series B Preferred Stock. As a result of the above Reorganization, Mr. Iglesias acquired at the time a controlling interest of the Company (see Note 4). On May 21, 2018, the Company filed a Certificate of Amendment with the Secretary of State of Nevada to change the Companys name from Biotech Products Services and Research, Inc. to Organicell Regenerative Medicine, Inc., effective June 20, 2018 (the Name Change). The Name Change has not yet been effectuated in the marketplace by the Financial Industry Regulatory Agency (FINRA). Since the June 2015 change in control of our Company and the July 2015 change in the Companys operations, the Company has been engaged in the health care industry, principally focusing on supplying products and services related to the growing field of regenerative anti-aging medicine. For the six months ended April 30, 2018, the Company principally operated through the following wholly owned subsidiaries: General Surgical of Florida, Inc., a Florida corporation (General Surgical) with a business purpose to sell cellular therapy products to doctors and hospitals and Anu Life Sciences, Inc. (ANU), a Florida corporation with a business purpose of the development, production and manufacturing of anti-aging and cellular therapy products until February 5, 2018 (see below). ANU began operations during November 2016 and commenced sales of its first product offering during February 2017. As described in Note 3, on February 5, 2018, ANU sold or transferred to Vera Acquisition LLC, a Utah limited liability company ("Vera") their right, title and interest in certain tangible and other assets associated with its manufacturing operations in exchange for a cash payment of $950,000 and the execution of a long term distribution agreement between Vera and the Company (Sale) which provided the Company certain exclusive and non-exclusive rights to distribute future products to be manufactured by Vera, including products that were developed and produced by ANU and additional products that may be developed and produced by Vera in the future. After the completion of the Sale and up thru April 2019, the Company remained in the business of selling and distributing regenerative biologic therapies based on amnion placental tissue derived products to doctors and hospitals but relied on third party supply agreements, rather than from products manufactured internally, for the supply of these advanced biologically processed cellular and tissue based products. During February 2019, the Company began arranging to operate a new laboratory facility for the purpose of performing research and development, production and manufacturing of anti-aging and cellular therapy products. This new laboratory facility became operational in May 2019 and during the same period, the Company began producing and distributing the products that are being sold to its customers. Mint Organics, Inc. (Mint Organics) a Florida corporation and a 77.5%-owned subsidiary of the Company as of April 30, 2018, and Mint Organics Florida, Inc., (Mint Organics Florida), a Florida corporation and a 96%-owned subsidiary of Mint Organics, were both formed with a business purpose of operating Medical Marijuana Treatment Centers (MMTC) for defined MMTC licensed activities (see Note 14). Both companies began development of the business during February 2017. As of October 31, 2017, Mint Organics and Mint Organics Florida had not been successful in obtaining the required licenses to operate MMTCs and each entity had exhausted all of their working capital and therefore neither was able to continue efforts towards development of that business. On April 6, 2018, Mr. Taddeo resigned as the Chief Executive Officer and member of the Board of Directors of Mint Organics and Mint Organics Florida and since that date, the Company has not pursued any additional efforts to obtain licenses to operate MMTCs. Beyond Cells Corp., a Florida corporation (Beyond Cells) formed with a business purpose to provide anti-aging and cellular therapy patient marketing and product sales has not had any operating activities subsequent to the year ended October 31, 2017. Ethan New York, Inc., a New York corporation (Ethan NY), formed with a business purpose of selling clothing and accessories through a retail store, closed operations during June 2016 and the results of Ethan NY are reflected as discontinued operations in the financial statements.